Xiaoxing Xing Qiu

US Patent:

6818392, Nov 16, 2004

Filed:

Dec 6, 2000

Appl. No.:

09/731126

Inventors:

Sheng C. Lou - Libertyville IL
Jeffrey C. Hunt - Mundelein IL
John G. Konrath - Lake Villa IL
Xiaoxing Qiu - Gurnee IL
James W. Scheffel - Mundelein IL
Joan D. Tyner - Beach Park IL

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

C12Q 170

US Classification:

435 5, 435 71, 435339, 4353391, 4241881, 4242081, 5303883, 53038835

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7528238, May 5, 2009

Filed:

Sep 14, 2004

Appl. No.:

10/940162

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories, Inc. - Abbott Park IL

International Classification:

C12P 21/08

US Classification:

53038835, 422 61

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7531638, May 12, 2009

Filed:

Sep 14, 2004

Appl. No.:

10/940237

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories, Inc. - Abbott Park IL

International Classification:

C12P 21/08

US Classification:

53038835

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7531639, May 12, 2009

Filed:

Sep 14, 2004

Appl. No.:

10/940261

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories, Inc. - Abbott Park IL

International Classification:

C12P 21/08

US Classification:

53038835, 422 61

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7531640, May 12, 2009

Filed:

Sep 14, 2004

Appl. No.:

10/940262

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories, Inc. - Abbott Park IL

International Classification:

C12P 21/08

US Classification:

53038835, 422 61

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7531641, May 12, 2009

Filed:

Sep 14, 2004

Appl. No.:

10/940344

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories, Inc. - Abbott Park IL

International Classification:

C12P 21/08

US Classification:

53038835, 422 61

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7531642, May 12, 2009

Filed:

Sep 14, 2004

Appl. No.:

10/940392

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories, Inc. - Abbott Park IL

International Classification:

C12P 21/08

US Classification:

53038835

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.

US Patent:

7897332, Mar 1, 2011

Filed:

Nov 17, 2003

Appl. No.:

10/714689

Inventors:

Sheng C. Lou - Libertyville IL, US
Jeffrey C. Hunt - Mundelein IL, US
John G. Konrath - Lake Villa IL, US
Xiaoxing Qiu - Gurnee IL, US
James W. Scheffel - Mundelein IL, US
Joan D. Tyner - Beach Park IL, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

C12Q 1/70
G01N 33/53
A61K 39/42

US Classification:

435 5, 435 71, 4241481, 4241601

Abstract:

The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.